This congress is organized by BIT Life Sciences and will present topics concerning the very current advancements in antibody research and product development. Discussion areas will focus on the Emerging Antibody Technologies, Antibody Molecular Targets of Cancers, Targeting Therapeutic Monoclonal Antibody research and development for Major Cancers, Therapeutic MAbs for Various Human Major Diseases, Preclinical /Clinical Studies of Monoclonal Therapeutics, Antibodies for Clinical Diagnostics and Therapy, Antibody Engineering and Production, and Bio-Venture on Antibodies.

BIT Life Sciences and Organizing Committee are organizing the 2nd BIT Life Sciences’ Annual World Congress of Vaccine (WCV) as part of their dedication to offer professionals in Vaccine filed a multidisciplinary platform to learn about the latest scientific updates and current industry standard. The congress with the theme “Next Generation Vaccines” will be held during March 24–26, 2010, atBeijing International Convention Center, Beijing, China. On behalf of organizing committee, we are pleased to network and explore partnering opportunities. BIT Life Sciences’ Annual World Congress of Vaccine is best known as the largest meeting devoted exclusively to the research on vaccines and associated technologies for disease prevention and treatment in China.

The mission of this symposium is to bring together professionals and those who are interested in enzyme and biocatalysts technology to share the recent developments and future trends in the fields of basic researches and applications of enzymes in industry, analysis, and medicine. As the demand for enzymes has grown at a fast pace in the past decade, both production and demand will continue to grow in the next few years. This focused event pays tribute to the growing significance of technologies for enzyme and biocatalysis.

The BIT Life Sciences' Annual World Cancer Congress is a China-based, interactive conference providing practicing oncologists with the latest research on epidemiologic, cancer molecular mechanisms, drug discovery, therapeutics development, diagnosis, clinical data, best practices, and new technologies that are directly applicable to the practice of cancer research and therapeutic discovery and development. The conference will provide participants a face-to-face platform to exchange ideas, share update breakthroughs and promising solutions to most important issues in the area. Based on the program in previous years, this Breast Cancer Conference is our intention to focus on most relevant and controversial topics on biology, diagnosis and treatment of breast cancer, it will provide the participants on recent advices and current challenges in this area. Contents will be developed in Symposia, Plenary Lectures, co-current Sessions and Clinical Cases discussions.

The mission of this congress is to initiate a sustainable platform for exchanging up-to-the-minute upstream and downstream achievements, industrial needs, and research opportunities of industrial biotechnology fields in Asia Pacific Rim. As industrial biotechnology is currently experiencing a dramatic increasing, it has become a key element of the interactions between nature and society and is considered a key input for bioeconomic development. This focused event pays tribute to the growing significance of Industrial Biotechnology, we cordially welcome you to join us and witness the advances in industrial biotechnology together.

This major symposium is in honor of the distinguished work and lifetime achievements of Professor Derek Fray, who is a well-known figure for his deep impact in materials extraction and processing world. He is author of almost 400 scientific papers and inventor on approximately 179 patents arising from 62 families of patents. The scope of this symposium will be based on the equally important three topical areas: principles, technologies, and industrial practice with special emphasis on a globally sought clean environment of 21 century. It will include but it is not limited to nonferrous metal extraction, processing, and sulfide smelting (including light metals, PMG, and Ferro alloys); iron and steel production; mineral processing; chemical and metallurgical process reactors; refractory materials; recycling, waste treatment, soil remediation, and biotechnologies; chemistry of power and energy generation; composite, hybrid, polymeric, ceramic materials, and nanomaterials; value addition and advanced materials; as well as legal and management, and environmental related issues.